These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35347083)

  • 1. Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine.
    Pun FW; Leung GHD; Leung HW; Liu BHM; Long X; Ozerov IV; Wang J; Ren F; Aliper A; Izumchenko E; Moskalev A; de Magalhães JP; Zhavoronkov A
    Aging (Albany NY); 2022 Mar; 14(6):2475-2506. PubMed ID: 35347083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive AI-driven analysis of large-scale omic datasets reveals novel dual-purpose targets for the treatment of cancer and aging.
    Pun FW; Leung GHD; Leung HW; Rice J; Schmauck-Medina T; Lautrup S; Long X; Liu BHM; Wong CW; Ozerov IV; Aliper A; Ren F; Rosenberg AJ; Agrawal N; Izumchenko E; Fang EF; Zhavoronkov A
    Aging Cell; 2023 Dec; 22(12):e14017. PubMed ID: 37888486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform.
    Olsen A; Harpaz Z; Ren C; Shneyderman A; Veviorskiy A; Dralkina M; Konnov S; Shcheglova O; Pun FW; Leung GHD; Leung HW; Ozerov IV; Aliper A; Korzinkin M; Zhavoronkov A
    Aging (Albany NY); 2023 Apr; 15(8):2863-2876. PubMed ID: 37100462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery.
    Kamya P; Ozerov IV; Pun FW; Tretina K; Fokina T; Chen S; Naumov V; Long X; Lin S; Korzinkin M; Polykovskiy D; Aliper A; Ren F; Zhavoronkov A
    J Chem Inf Model; 2024 May; 64(10):3961-3969. PubMed ID: 38404138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying Artificial Intelligence to Identify Common Targets for Treatment of Asthma, Eczema, and Food Allergy.
    Liu HM; Rayner A; Mendelsohn AR; Shneyderman A; Chen M; Pun FW
    Int Arch Allergy Immunol; 2024; 185(2):99-110. PubMed ID: 37989115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics - An AI-Enabled Biological Target Discovery Platform.
    Pun FW; Liu BHM; Long X; Leung HW; Leung GHD; Mewborne QT; Gao J; Shneyderman A; Ozerov IV; Wang J; Ren F; Aliper A; Bischof E; Izumchenko E; Guan X; Zhang K; Lu B; Rothstein JD; Cudkowicz ME; Zhavoronkov A
    Front Aging Neurosci; 2022; 14():914017. PubMed ID: 35837482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using artificial intelligence methods to speed up drug discovery.
    Álvarez-Machancoses Ó; Fernández-Martínez JL
    Expert Opin Drug Discov; 2019 Aug; 14(8):769-777. PubMed ID: 31140873
    [No Abstract]   [Full Text] [Related]  

  • 9. AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor.
    Ren F; Ding X; Zheng M; Korzinkin M; Cai X; Zhu W; Mantsyzov A; Aliper A; Aladinskiy V; Cao Z; Kong S; Long X; Man Liu BH; Liu Y; Naumov V; Shneyderman A; Ozerov IV; Wang J; Pun FW; Polykovskiy DA; Sun C; Levitt M; Aspuru-Guzik A; Zhavoronkov A
    Chem Sci; 2023 Feb; 14(6):1443-1452. PubMed ID: 36794205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precious1GPT: multimodal transformer-based transfer learning for aging clock development and feature importance analysis for aging and age-related disease target discovery.
    Urban A; Sidorenko D; Zagirova D; Kozlova E; Kalashnikov A; Pushkov S; Naumov V; Sarkisova V; Leung GHD; Leung HW; Pun FW; Ozerov IV; Aliper A; Ren F; Zhavoronkov A
    Aging (Albany NY); 2023 Jun; 15(11):4649-4666. PubMed ID: 37315204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemistry42: An AI-Driven Platform for Molecular Design and Optimization.
    Ivanenkov YA; Polykovskiy D; Bezrukov D; Zagribelnyy B; Aladinskiy V; Kamya P; Aliper A; Ren F; Zhavoronkov A
    J Chem Inf Model; 2023 Feb; 63(3):695-701. PubMed ID: 36728505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Industrializing AI-powered drug discovery: lessons learned from the
    Guedj M; Swindle J; Hamon A; Hubert S; Desvaux E; Laplume J; Xuereb L; Lefebvre C; Haudry Y; Gabarroca C; Aussy A; Laigle L; Dupin-Roger I; Moingeon P
    Expert Opin Drug Discov; 2022 Aug; 17(8):815-824. PubMed ID: 35786124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming drug discovery with a high-throughput AI-powered platform: A 5-year experience with Patrimony.
    Blaudin de Thé FX; Baudier C; Andrade Pereira R; Lefebvre C; Moingeon P;
    Drug Discov Today; 2023 Nov; 28(11):103772. PubMed ID: 37717933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus.
    Reker D; Rodrigues T; Schneider P; Schneider G
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4067-72. PubMed ID: 24591595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial intelligence for aging and longevity research: Recent advances and perspectives.
    Zhavoronkov A; Mamoshina P; Vanhaelen Q; Scheibye-Knudsen M; Moskalev A; Aliper A
    Ageing Res Rev; 2019 Jan; 49():49-66. PubMed ID: 30472217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological drug discovery: AI meets structure-based computational research.
    Gorostiola González M; Janssen APA; IJzerman AP; Heitman LH; van Westen GJP
    Drug Discov Today; 2022 Jun; 27(6):1661-1670. PubMed ID: 35301149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing preclinical drug discovery with artificial intelligence.
    Vijayan RSK; Kihlberg J; Cross JB; Poongavanam V
    Drug Discov Today; 2022 Apr; 27(4):967-984. PubMed ID: 34838731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery.
    Tong X; Qu N; Kong X; Ni S; Zhou J; Wang K; Zhang L; Wen Y; Shi J; Zhang S; Li X; Zheng M
    Nat Commun; 2024 Jun; 15(1):5378. PubMed ID: 38918369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases.
    Berenstein AJ; Magariños MP; Chernomoretz A; Agüero F
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004300. PubMed ID: 26735851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.